GLOBAL IMMUNE TECHNOLOGIES INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
GLOBAL IMMUNE TECHNOLOGIES INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$2.37 million for the 153-month period ending 2011-12-31, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2012-11-19
- GLOBAL IMMUNE TECHNOLOGIES INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2011-12-31 was -$7.50K.
- GLOBAL IMMUNE TECHNOLOGIES INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-12-31 was -$28.34K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 150 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 153 month |
|---|---|---|---|---|---|
| 2011-12-31 | -$7.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | -$22.50K 10-Q · filed 2012-11-19 | -$2.37M 10-Q · filed 2012-11-19 | ||
| 2011-09-30 | -$15.00K 10-Q · filed 2012-11-19 | -$2.36M 10-Q · filed 2012-11-19 | |||
| 2010-12-31 | -$28.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | -$48.11K 10-Q · filed 2012-11-19 | |||
| 2010-09-30 | -$19.77K 10-Q · filed 2012-11-19 |